40. Ooi, V. E., and F. Liu, “Immunomodulation and Anti-Cancer Activity of Polysaccharide-Protein Complexes,”
41. Torisu, M., Y. Tayashi, T. Ishimitsu, et al., “Significant Prolongation of Disease-Free Period Gained by Oral Polysaccharide K (PSK) Administration After Curative Surgical Operation of Colorectal Cancer,”
42. Nakazato, H., A. Koike, S. Saji, et al., “Efficacy of Immunochemotherapy as Adjuvant Treatment After Curative Resection of Gastric Cancer,”
43. Hara, M., T. Hanaoka, M. Kobayashi, et al., “Cruciferous Vegetables, Mushrooms, and Gastrointestinal Cancer Risks in a Multicenter, Hospital-Based Case-Control Study in Japan,”
44. Torisu, Tayashi, Ishimitsu, et al., “Significant Prolongation of Disease-Free Period . . . ”
45. Kikuchi, Y., I. Kizawa, K. Oomori, et al., “Effects of PSK on Interleukin-2 Production by Peripheral Lymphocytes of Patients with Advanced Ovarian Carcinoma During Chemotherapy,”
46. Tsujitani, S., Y. Kakeji, H. Orita, et al., “Postoperative Adjuvant Immunochemotherapy and Infiltration of Dendritic Cells for Patients with Advanced Gastric Cancer,”
47. Kariya, Y., N. Inoue, T. Kihara, et al., “Activation of Human Natural Killer Cells by the Protein-Bound Polysaccharide PSK Independently of Interferon and Interleukin 2,”
48. Mizutani, Y., and O. Yoshida, “Activation by the Protein-Bound Polysaccharide PSK (Krestin) of Cytotoxic Lymphocytes That Act on Fresh Autologous Tumor Cells and T24 Human Urinary Bladder Transitional Carcinoma Cell Line in Patients with Urinary Bladder Cancer,”
49. Torisu, Tayashi, Ishimitsu, et al., “Significant Prolongation of Disease-Free Period . . .”
50. Labrecque, L., S. Lamy, A. Chapus, et al., “Combined Inhibition of PDGF and VEGF Receptors by Ellagic Acid, a Dietary-Derived Phenolic Compound,”
51. Ibid.
52. Hanausek, M., Z. Walaszek, and T. J. Slaga, “Detoxifying Cancer Causing Agents to Prevent Cancer,”
53. Seeram, N., L. Adams, Y. Zhang, et al., “Blackberry, Black Raspberry, Blueberry, Cranberry, Red Raspberry, and Strawberry Extracts Inhibit Growth and Stimulate Apoptosis of Human Cancer Cells in Vitro,”
54. Béliveau, R., and D. Gingras,
55. Stoner, G. D., et al., “Cancer Prevention with Freeze-Dried Berries and Berry Components,”
56. Stoner, G. D., “Commentary—Foodstuffs for Preventing Cancer: The Preclinical and Clinical Development of Berries,”
57. Vizzotto, M., “Inhibition of Invasive Breast Cancer Cells by Selected Peach and Plum Phenolic Antioxidants” (PhD diss., Texas A&M University, August 2005).
58. Altman, L. K., “New Drug Fights Second Kind of Cancer,”
59. Folkman J., and R. Kalluri, “Cancer Without Disease,”
60. Plouzek, C. A., H. P. Ciolino, R. Clarke, et al., “Inhibition of P-glycoprotein Activity and Reversal of Multidrug Resistance in Vitro by Rosemary Extract,”
61. Lamy, S., et al., “The Dietary Flavonols Apigenin and Luteolin Inhibit PDGF-Dependent Vascular Smooth Muscle Cell Migration,”
62. Béliveau, R., and D. Gingras,
63. Yokoi, K., T. Sasaki, C. D. Bucana, et al., “Simultaneous Inhibition of EGFR, VEGFR, and Platelet-Derived Growth Factor Receptor Signaling Combined with Gemcitabine Produces Therapy of Human Pancreatic Carcinoma and Prolongs Survival in an Orthotopic Nude Mouse Model,”
64. Ramesha, A., N. Rao, A. R. Rao, et al., “Chemoprevention of 7,12-Dimethylbenz- [a]anthracene-Induced Mammary Carcinogenesis in Rat by the Combined Actions of Selenium, Magnesium, Ascorbic Acid and Retinyl Acetate,”
65. Ibid.
